EXECUTIVE MANAGEMENT AND BONUS AGREEMENTExecutive Management and Bonus Agreement • March 4th, 2014 • Immunoclin Corp • Services-computer processing & data preparation
THIS AGREEMENT (the "Agreement") effective as of this Twenty-third (23rd) day of January 2014 (the “Effective Date”), entered into between Pharma Investing News, Inc. a Nevada Corporation, with its principal offices located at 9107 Wilshire Blvd, Suite 450, Beverly Hills, CA 90210 (the “Company” or “PINV”) and Dr. Khadija Benlhassan of Paris, France and/or her assigns (the “Executive”) (together, the Company and the Executive may be referred to herein as the "parties", or each individually as a "party").
DEBT SETTLEMENT AGREEMENTDebt Settlement Agreement • September 29th, 2014 • Immunoclin Corp • Miscellaneous food preparations & kindred products
The Company wishes to settle the Debt by issuing to the Creditor, or its assigns, shares of common stock of the Company and the Creditor is prepared to accept the shares in full satisfaction of the Debt.
CONTROL SHAREHOLDER AGREEMENTControl Shareholder Agreement • December 20th, 2013 • Pharma Investing News, Inc. • Services-computer processing & data preparation • Nevada
Pharma Investing News, Inc. ("PINV" or the "Corporation"), a Nevada corporationwith its corporate offices located at 9107 Wilshire Blvd., Suite 450, Beverly Hills, CA 90210.
BUSINESS DEVELOPMENT SERVICE AGREEMENTBusiness Development Service Agreement • December 22nd, 2014 • Immunoclin Corp • Services-computer processing & data preparation • Nevada
JAGPAL HOLDINGS INC, a company organized and existing under the laws of Belize, with its principal place of business located at 1 Mapp Street, Belize City, Belize represented by Mr. Amandip Jagpal, acting as President (the “Provider”)
PRODUCT MARKETING SERVICE AGREEMENT This Agreement is made effective as of October 31, 2014 by and between: Mr. Kamal Etefia,an individual having an address at 2 Allée Scheurer Kestner 92150 SURESNES, France (the “Provider”) ANDProduct Marketing Service Agreement • December 22nd, 2014 • Immunoclin Corp • Services-computer processing & data preparation • Nevada
ImmunoClin Corporation, 1800 Wyoming Avenue, NW, 3rd Floor, Washington, DC 20009 USA, represented by Dr. Dorothy Bray, acting as Director, President and CEO (the “Recipient”)
SUBSCRIPTION AGREEMENT Pharma Investing News, Inc.Subscription Agreement • May 17th, 2011 • Pharma Investing News, Inc.
BUSINESS DEVELOPMENT SERVICE AGREEMENTBusiness Development Service Agreement • December 22nd, 2014 • Immunoclin Corp • Services-computer processing & data preparation • Nevada
ImmunoClin Corporation, a company organized and existing under the laws of the State of Nevada, with its principal place of business located at 1800 Wyoming Avenue, NW, 3rd Floor, Washington, DC 20009 USA, represented by Dr. Dorothy Bray, acting as Director, President and CEO (the “Recipient”)
TAKEOVER AGREEMENTTakeover Agreement • December 20th, 2013 • Pharma Investing News, Inc. • Services-computer processing & data preparation • Nevada
For the purposes of this Agreement, the following terms and variations on them have the meanings specified in this Section 1:
JOINT VENTURE AGREEMENTJoint Venture Agreement • July 27th, 2011 • Pharma Investing News, Inc. • Services-computer processing & data preparation
This Joint Venture Agreement (the “Agreement”), is made and entered into on July 22, 2011, by and between Healthcare Media (“Healthcare”) and Pharma Investing News, Inc., a Nevada corporation (“Pharma”), with an effective date of May 1, 2011 (the “Effective Date”). Each of the parties to this Agreement is individually referred to herein as a “Party” and collectively as the “Parties.”
MANAGEMENT AND BONUS AGREEMENTManagement and Bonus Agreement • December 20th, 2013 • Pharma Investing News, Inc. • Services-computer processing & data preparation
THIS AGREEMENT (the "Agreement") effective as of this thirteenth (13th) day of December 2013 (the “Effective Date”), entered into between Pharma Investing News, Inc. a Nevada Corporation, with its principal offices located at 9107 Wilshire Blvd, Suite 450, Beverly Hills, CA 90210 (the “Company” or “PINV”) and Raymond Dabney of Vancouver, BC, Canada (the “Consultant”) (together, the Company and the Consultant may be referred to herein as the "parties", or each individually as a "party").
